CAROL HILL: Open Payments
NPI 1346935145 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,146 in 111 payments from 11 companies in 2025. Trend: 2023 $561 · 2024 $1,396 · 2025 $2,146
Food & beverage: $2,056Education: $90
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $434 |
| UCB, Inc. | 25 | $426 |
| ABBVIE INC. | 25 | $380 |
| Janssen Biotech, Inc. | 7 | $287 |
| AstraZeneca Pharmaceuticals LP | 9 | $234 |
| Mallinckrodt Hospital Products Inc. | 5 | $144 |
| PFIZER INC. | 3 | $70 |
| Lilly USA, LLC | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
Products named: Bimzelx, TREMFYA, KRYSTEXXA, RINVOQ, SAPHNELO, SKYRIZI, ACTHAR, EVENITY.
Industry payments across FL — which companies pay providers there.
